The FDA recently approved Brixadi to treat moderate to severe opioid use disorder in patients who have already started treatment with a transmucosal form of buprenorphine, and have approved Opvee as an emergency treatment to reverse known or suspected opioid overdose in people ages 12 years and older.
Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
Since 2017, two lawsuits and two state audits have cast a harsh light on Medicaid managed care, which served 845,000 adults and children at a cost of almost $6 billion last year.
The Cyltezo Pen is scheduled to be on the market and available on July 1.
Labs are justifying larger respiratory panels as simplifying a physician’s job in diagnosing via lab testing, but payers need to observe the multiplex testing trend.
Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.
Eric Hunter, president and CEO of CareOregon, and editorial advisory board member of Managed Healthcare Executive, talks with MHE about the “combination” underway between CareOrgeon and SCAN Health and how it's a good thing amid the concerns it would make CareOregon less responsive to local needs. Hunter also talks about how the combination will affect how they manage pharmacy benefits, and what else is on their radar in healthcare.
The compulsory orders will require the GPOs, which negotiate drug rebates on behalf of other PBMs, to provide information and records on their business practices.
President and CEO of CareOregon, Eric Hunter, talks with MHE about what’s on his mind when it comes to healthcare. Throughout the discussion, MHE editors got an idea of how Medicaid redetermination is going for CareOregon, and took a deeper look at the collaboration or “combination” underway between SCAN Health and CareOrgeon.
The Federal Trade Commission is casting a wider net in its ongoing inquiry of pharmacy benefit managers (PBMs).
But higher costs for cancer drugs did not influence some common measures of adherence, such as medication possession ratio and proportion of days. The researchers believe that cancer patients may be more likely to adhere to medication regimen, regardless of price, because the drugs are critical for survival.
The theory behind smishing is similar to that of phishing. The difference is that smishing happens via a person’s smartphone.
There are many reasons the ransomware problem has been hard to stop. One reason is that ransomware is good business. A 2021 U.S. Treasury Department identified more than $5 billion worth of outgoing bitcoin cryptocurrency payments it suspects may have been related to ransomware attacks.
Results from a recent study published in JAMA Network displayed key thematic shifts and increases in language related to anxiety, anger, depression, and loneliness during the pandemic.
The National Community Pharmacists Association now has plenty of allies in its fight with the pharmacy benefit managers.
The COVID-19 pandemic normalized telehealth. Now an increasing number of insurers are offering virtual-first plans that make virtual care the default choice.
The FDA approved Rexulti (brexpiprazole) for Alzheimer’s-related agitation based on the findings of two clinical trials.
A wholesale acquisition cost (WAC) for Elfabrio will be announced once it is available in a few weeks.
This month’s episode of the "What's On Your Mind" podcast series features Eric Hunter, president and CEO of CareOregon. MHE Managing Editor Peter Wehrwein, Editor Briana Contreras and Hunter discuss Medicaid redetermination and merger of CareOregon and the California-based insurer, SCAN Group.
Using a national database, data on medication purchases was collected, along with factors that may have influenced expenditures, such as new therapy availability, patent expirations, policy changes, and legislation.
Researchers of a study examined the gender-specific COVID-19 case fatality risks among patients with a malignant neoplasm during hospital admissions as there is little data available for gender-specific COVID-19 mortality.
Accessible through the CareFirst WellBeing app, these behavioral health services are working to combat health risks related to obesity.
The Office of Civil Rights published a proposed rule that could have healthcare organizations evaluating their practices surrounding, and interactions with, reproductive healthcare information.
Reasons behind asthma care lacking for low-income patients run wide. However, cost seems to be the main issue.
Bill Snyder, CEO of Vivante Health, explains how the organization's digestive health service through digital health is benefiting patients by personalizing their care and being supported in their care journey with the help of their primary care physician or gastroenterologist.
CEO of Vivante Health, Bill Snyder, shares how an integrated or "full-stack" digital health system can benefit patient care all around, amid safety concerns about digital health and the security of sensitive health information. Snyder also introduces Vivante's digestive health platform and how it's associated with the organization's digital health innovations. For example, they've invested in looking at disparate data sets and using AI and machine learning to leverage pattern recognition and recognize specific patient needs.
Over 7,000 people attended the meeting in Las Vegas this week.
This month's episode of Tuning In to the C-Suite features Erica Jain, CEO & co-founder of digital health company, Healthie. In this discussion, Jain shared some of the challenges or things to avoid when creating a digital health startup, based on her journey with starting Healthie in 2016. She also addressed some best practices and tools that can help those working toward a digital health startup.
